Please login to the form below

How to innovate and influence people in times of misinformation

The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the right approach to help companies with breakthrough innovations in their pipeline build consumer confidence.

Rewind to late 2019. If you had been told that within a few months, you’d be living in the middle of the biggest pandemic since the 1918 global flu outbreak, but that thanks to new mRNA technology, vaccine prototypes would be ready for trials within weeks and the first shots would go into arms before the end of 2020, what would you have thought?

You could be forgiven for assuming that people would marvel in unison about the miracle of modern medical science. Alas, it didn’t quite go that way.

While most people were relieved to be able to get their shots so soon, a significant section of society went the opposite way and refused to get vaccinated. Some were simply hesitant because they lacked information. A good portion of that group has come around by now. But in the end, the refusal camp was strong enough to hamstring the U.S. vaccination effort, which left us more vulnerable to Delta-driven COVID surges in the summer and fall of 2021, as well as the Omicron variant that showed up toward the end of the year.

Considering what else is in the technology pipeline, that should give us all pause. If the medical sector can’t get a handle on the growing public trust disconnect, it will mean significant dollars lost. But it will also mean that breakthrough innovations will fail to make their full positive impact, which would ultimately create significant adverse public health impacts.

Read the full article on the Stonearch Creative website

11th January 2022



Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

No. 3 Booths Park
Booths Hall
Chelford Road
WA16 8GS
United Kingdom

Latest content on this profile

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in a digital world.
Fishawack Health
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness.
Fishawack Health
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for measuring omnichannel maturity.
Fishawack Health
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.
Fishawack Health
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the roles of sales representatives and MSLs can evolve to drive greater personalization.
Fishawack Health
The digital-first launch: the key to connected stakeholder experiences?
During the COVID-19 pandemic, a new digital-first launch model emerged as a gamechanger for driving better customer experiences. Here, Senior Consultant Srividya Sekar; Senior Associate Consultant, Erin Johnstone; and Associate Consultant, Oliver Longstaff, discuss the benefits of the new model and how life science companies can leverage the benefits of digital communication early on to drive a connected and agile launch.
Fishawack Health